Salanga, Emanilyn .
HRN: 27-43-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/22/2026
AMPICILLIN 1GM (VIAL)
01/22/2026
01/22/2026
IV
2g
Q6hr
PROM X 3 Hrs
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: